UP FRONT
the Molecular Oncology Department.
This is a first-of-its-kind program that
combines the resources of the Molecular Oncology Department (which
investigates the biology of cancer and
tumors at the cellular level to identify
genes and non-coding RNAs involved
in tumor initiation, progression, maintenance, and metastasis) with those
of the Cancer Biology and Evolution
Program to potentially develop novel
treatments.
Timothy Kuzel Appointed
Division Chief of
Hematology, Oncology,
and Cell Therapy at Rush
University Medical Center
Timothy M. Kuzel, MD, was appointed
division chief of hematology, oncology,
and cell therapy at Rush University
Medical Center, effective in June. He
succeeded Philip D. Bonomi, MD, the
Alice Pirie Wirtz Professor of Medical Oncology, who stepped down from
the position but continues to treat
patients at the center. The division
oversees the diagnosis and treatment
of patients with solid tumors and
blood cancers.
Dr. Kuzel was previously director of
Northwestern University’s Driskill Immunotherapy Research Program, was a
professor of medicine and dermatology
at the Northwestern
University Feinberg
School of Medicine, and
oversaw the Genitourinary and Cutaneous
Oncology Programs
at the Robert H. Lurie
Comprehensive Cancer
Center.
Timothy M. Kuzel, MD
Source: Rush University Medical Center press release,